Salute e Benessere

RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%…

NEWS RELEASERECORDATIFIRSTNINEMONTHS2025RESULTS: REVENUE +12.2%, EBITDA (1) +11.8%, ADJUSTED NET INCOME (2) +10.7%; ISTURISAPEAKSALESESTIMATEDOUBLEDTOGREATERTHAN€1.2BILLION Consolidated net revenue of € 1,956.2 million in the first nine months of 2025, +12.2% or +8.1% on a like-for-like basis(3) and at constant exchange rates (CER)EBITDA(1)of€743.9million,+11.8%,marginonrevenueof38.0%Adjustednet...

Waters Corporation to Present at the Jefferies Global Healthcare Conference in…

About Waters Corporation About Waters Corporation Waters Corporation (NYSE:WAT) is a global leader in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences for over 65 years. Our Company helps ensure the efficacy of medicines, the safety of food and the purity of water, and the quality and sustainability of products used every day. In over 100 countries, our 7,600+ passionate employees collaborate with customers in...

Interventional Oncology Market to Reach $4.38 Billion by 2030 at CAGR 8.55% -…

Request or download a free sample copy of this report: Interventional Oncology Market Request or download a free sample copy of this report:Interventional Oncology Market The industry is responding to the urgent need for effective cancer treatments through active strategic initiatives and significant investment. Companies are dedicated to developing advanced solutions to improve patient care; for example, Terumo launched a dedicated global therapeutic interventional oncology team to...

Medical Device Outsourcing Market to hit $386.08 Billion by 2033 - Grand View…

The market is classified by service into contract manufacturing, quality assurance, regulatory affairs, product design & development, product testing & sterilization, product implementation, product upgrade, and product maintenance services, with contract manufacturing services accounting for the largest revenue share at 55.1% in 2024. This dominance is fueled by market players striving to reduce costs due to shrinking profit margins, which involves implementing shift work to curtail…

DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing

DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR DealingDXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 11 November, Mr Bob Sutcliffe, the Chairman, purchased 50,000 Ordinary Shares in the Company at a price of 1.30p per share.Following this transaction Mr Sutcliffe and his wife’s...

Meet Raccoon 2 SE on Kickstarter -- Bringing AI-Powered Mowing to Small Gardens

Forget the hassle of boundary wires or complicated RTK installations. With Raccoon 2 SE, users can start mowing straight out of the box. No wiring, no setup, no stress. Just press mow and let the Raccoon 2 SE take care of the rest. Forget the hassle of boundary wires or complicated RTK installations. With Raccoon 2 SE, users canstart mowing straight out of the box. No wiring, no setup, no stress. Just press mow and let the Raccoon 2 SE take care of the rest. "True to its "Just Press...

Molecular Spectroscopy Market to Reach $6.4 billion, Globally, by 2034 at 5%…

Request Sample of the Report on Molecular Spectroscopy Market Forecast 2034 - https://www.alliedmarketresearch.com/request-sample/A34944 Request Sample of the Report on Molecular Spectroscopy Market Forecast 2034 -https://www.alliedmarketresearch.com/request-sample/A34944 Market Introduction The molecular spectroscopy market encompasses a diverse range of analytical technologies used to study the interaction of electromagnetic radiation with matter, enabling precise...

Wastewater Surveillance Market worth $1.22 billion by 2030 with 6.7% CAGR |…

The range of testing capabilities has grown tremendously, driving the industry toward faster, more sensitive, and more affordable solutions. This includes progress in molecular diagnostics, next-generation sequencing (NGS), biosensors, multiplex PCR assays, and AI-powered data analytics for trend forecasting. The availability of portable, field-ready testing kits and cloud-based reporting platforms has further improved the speed and dependability of results. The range of testing capabilities...

Hair Salon Services Market to Reach $233.3 billion, Globally, by 2034 at 3.9%…

Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A325788 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A325788 Prime determinants of growth The hair salon services market is driven by factors such as rise in consumer focus on personal grooming and appearance, and influence of social media and celebrities. However, the availability of at-home and DIY skilled labor shortages and high...

Lexogen honored as one of Austria's Top Innovative Companies 2026 by Statista…

Supporting life science research and applications through innovation Supporting life science research and applications through innovation Founded inVienna, Austria, nearly two decades ago, Lexogen has always pursued a clear mission: tohelp scientists explore how genes workby developing advanced technologies to analyze RNA, the molecule that reveals gene activity. Theircomplete solutions for RNA and transcriptome analysis are used worldwideby researchers. These tools support both...

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…

Bagsværd, Denmark, 11 November 2025 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have reported the transactions to Novo Nordisk. 1 Details of the person discharging managerial responsibilities/person closely associated...

AC Immune to Present at the Jefferies 2025 London Healthcare Conference

AC Immune to Present at the Jefferies 2025 London Healthcare ConferenceLausanne, Switzerland, November 11, 2025 --AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced that Company Management will participate in a fireside chat and one-on-one investor meetings during the Jefferies Global Healthcare Conference in London, taking place November 17-20, 2025.The fireside chat will take place...

Zinzino AB (publ.): Zinzino acquires 35% of the shares in Andorra-based Xion…

Xion is an innovative production company with its own patents based in Spain that has developed one of the world's first high-tech photobioreactor systems for the production of the nutrient-rich microalgae spirulina. Xion's groundbreaking, award-winning technology, with a cultivation method based on nature's own principles, sets a new standard for sustainable, efficient, and clean production and creates great opportunities for large-scale cultivation and production of all types of…

Shilpa Pharma Lifesciences Awarded EcoVadis Gold Medal for Outstanding…

EcoVadis assesses organizations on four key pillars — Environment, Labor & Human Rights, Ethics, and Sustainable Procurement — and this recognition positions Shilpa Pharma Lifesciences among the top few global companies rated for sustainable business operations. EcoVadis assesses organizations on four key pillars — Environment, Labor & Human Rights, Ethics, and Sustainable Procurement — and this recognition positions Shilpa Pharma Lifesciences among the top few global companies rated…

Coloplast A/S - Notice of Annual General Meeting 2025

Notice of Annual General Meeting 2025The Annual General Meeting of Coloplast A/S will be held on Thursday, 4 December 2025 at 3:30 pm CET at the premises of Coloplast A/S, Holtedam 3 in Humlebæk (the Aage Louis-Hansen Auditorium), Humlebæk, Denmark.The notice of the Annual General Meeting is enclosed. For further information, please contact Investors and analysts Anders Lonning-Skovgaard Executive Vice President, CFO Tel. +45 4911 1111 Kristine Husted Munk Sr...

Apollo Cancer Centres Turns Chocolates into Health Reminders with 'Check-Olate'

Eminent breast oncologists at Apollo Cancer Centres stated that when it comes to breast cancer, early detection isn't just important, it's lifesaving. They stressed the fact that ACCs have witnessed firsthand how timely screening and awareness have helped save numerous women through early-stage diagnosis and treatment. Eminent breast oncologists at Apollo Cancer Centres stated that when it comes to breast cancer, early detection isn't just important, it's lifesaving. They stressed the fact…

Shilpa Medicare Announces Positive Phase 3 Results for OERIS™ -- A Novel…

This milestone underscores Shilpa's growing leadership in differentiated drug-delivery systems and oncology supportive-care therapeutics, reflecting the company's commitment to advancing patient-centric innovation. This milestone underscores Shilpa's growing leadership indifferentiated drug-delivery systemsandoncology supportive-care therapeutics, reflecting the company's commitment to advancing patient-centric innovation. Study Overview APhase III, multicenter, randomized,...

Commit Biologics achieves proof-of-concept for novel Complement Engager platform…

"The positive NHP results represent a major milestone for Commit Biologics. Not only do they validate that the complement system can be used to safely and effectively deplete cells of interest in a highly relevant model they also demonstrate the ability of our platform to generate novel therapeutics with a unique mechanism of action that can be applied across many different indications,"said Mikkel Wandahl Pedersen, Chief Executive Officer of Commit Biologics. "We are pleased to…

German health network chooses Sectra to improve diagnostics and reduce risk of…

Xcare Group is a private health network that comprises 12 sites across the Saarland and the Trier/Wittlich regions of Germany. They provide physician practices in the specialties of radiology, nuclear medicine, and radiation therapy, conducting approximately 200,000 radiology exams a year. The contract for Sectra's enterprise imaging solution was signed in the second quarter of Sectra's 2025/2026 fiscal year, and Xcare will utilize the solution's radiology module. Xcare Group is a private...

RefluxStop® takes center stage at 2025 European Foregut Society meeting

The RefluxStop Symposium, 'RefluxStop for GERD: Excellent long-term outcomes' drew a full house of around 100 doctors to hear about the device's rapidly evolving excellent long-term and real-world outcomes data. The distinguished panel of RefluxStop experts included: Prof. Sebastian Schoppmann, Dr. med. Yves Borbély, Dr. med. Moustafa Elshafei and Dr. med. Thorsten Lehmann. They provided an in-depth perspective on RefluxStop® to treat reflux disease, followed by constructive discussions with a…

Ariceum Therapeutics Doses First Patient in SANTANA-225 Phase 1/2 Clinical Trial…

225Ac-SSO110 has received U.S. FDA Orphan Drug DesignationInitial safety data from SANTANA-225 in ES-SCLC and MCC expected in 2026Potential to address a broad range of neuroendocrine cancersBERLIN, Nov.11, 2025(GLOBE NEWSWIRE) -- Ariceum Therapeutics (Ariceum), a targeted radiotherapeutics company dedicated to setting new standards in cancer care, today announced that the first patient has been dosed in the SANTANA-225 Phase 1/2 study of 225Ac-SSO110 for the treatment of...

Natura's corporate simplification progresses, while profitability was impacted…

The revenue decline, driven by consumption constraints in Brazil and temporary operational challenges in Argentina and Mexico — three markets that together represent around 85% of the business — resulted in lower expense dilution. As a result, the recurring EBITDA margin in Latin America was 11.7% (-360 bps). Gross margin remained healthy across the region. The revenue decline, driven by consumption constraints inBraziland temporary operational challenges inArgentinaandMexico— three...

Onward Therapeutics Completes Share Exchange and Establishes Global Headquarters…

Over the past six years, Onward has built a robust pipeline of four innovative programs targeting both solid and hematologic tumors, through in-licensing, acquisition, and internal discovery. The group reorganization was designed to align Onward's corporate structure with Taiwan's dynamic biotechnology capital market and to support the company's long-term growth plans, including future fundraising and potential public listing. Over the past six years, Onward has built a robust pipeline of…

Oropharyngeal Cancer Market to Register Steady CAGR Throughout Forecast Period…

Oropharyngeal Cancer Market Summary Oropharyngeal Cancer Market Summary Discover the oropharyngeal cancer new treatment @New Treatments for Oropharyngeal Cancer Key Factors Driving the Growth of the Oropharyngeal Cancer Market Rising Incidence of HPV+ Oropharyngeal Cancer HPV-driven OPSCC has increased sharply in many regions, shifting the disease burden and creating demand for new diagnostics and specialized treatments. Role of PD-1/PD-L1 Inhibitors PD-1...

Altri Comunicati